Barrett Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,050
| Closed | -$92K | – | 372 |
|
|
2021
Q4 | $92K | Hold |
1,050
| – | – | ﹤0.01% | 310 |
|
|
2021
Q3 | $86K | Hold |
1,050
| – | – | ﹤0.01% | 260 |
|
|
2021
Q2 | $96K | Hold |
1,050
| – | – | ﹤0.01% | 249 |
|
|
2021
Q1 | $90K | Hold |
1,050
| – | – | ﹤0.01% | 247 |
|
|
2020
Q4 | $99K | Hold |
1,050
| – | – | 0.01% | 220 |
|
|
2020
Q3 | $91K | Hold |
1,050
| – | – | 0.01% | 210 |
|
|
2020
Q2 | $92K | Buy |
1,050
+75
| +8% | +$6.47K | 0.01% | 201 |
|
|
2020
Q1 | $80K | Sell |
975
-225
| -19% | -$20.1K | 0.01% | 190 |
|
|
2019
Q4 | $114K | Buy |
1,200
+250
| +26% | +$22.4K | 0.01% | 188 |
|
|
2019
Q3 | $83K | Sell |
950
-1,000
| -51% | -$89.8K | 0.01% | 199 |
|
|
2019
Q2 | $178K | Sell |
1,950
-226
| -10% | -$19.1K | 0.01% | 158 |
|
|
2019
Q1 | $187K | Hold |
2,176
| – | – | 0.01% | 148 |
|
|
2018
Q4 | $167K | Hold |
2,176
| – | – | 0.01% | 149 |
|
|
2018
Q3 | $168K | Hold |
2,176
| – | – | 0.01% | 167 |
|
|
2018
Q2 | $147K | Sell |
2,176
-335
| -13% | -$23.1K | 0.01% | 170 |
|
|
2018
Q1 | $182K | Hold |
2,511
| – | – | 0.01% | 158 |
|
|
2017
Q4 | $189K | Hold |
2,511
| – | – | 0.01% | 155 |
|
|
2017
Q3 | $193K | Hold |
2,511
| – | – | 0.01% | 149 |
|
|
2017
Q2 | $188K | Buy |
2,511
+2,176
| +650% | +$154K | 0.01% | 149 |
|
|
2017
Q1 | $22K | Hold |
335
| – | – | ﹤0.01% | 280 |
|
|
2016
Q4 | $22K | Sell |
335
-335
| -50% | -$21.7K | ﹤0.01% | 280 |
|
|
2016
Q3 | $47K | Hold |
670
| – | – | ﹤0.01% | 218 |
|
|
2016
Q2 | $50K | Sell |
670
-26
| -4% | -$1.8K | ﹤0.01% | 217 |
|
|
2016
Q1 | $45K | Hold |
696
| – | – | ﹤0.01% | 214 |
|
|
2015
Q4 | $54K | Buy |
696
+26
| +4% | +$2.06K | ﹤0.01% | 203 |
|
|
2015
Q3 | $55K | Hold |
670
| – | – | 0.01% | 202 |
|
|
2015
Q2 | $59K | Hold |
670
| – | – | ﹤0.01% | 205 |
|
|
2015
Q1 | $59K | Hold |
670
| – | – | ﹤0.01% | 205 |
|
|
2014
Q4 | $56K | Hold |
670
| – | – | ﹤0.01% | 227 |
|
|
2014
Q3 | $56K | Hold |
670
| – | – | ﹤0.01% | 235 |
|
|
2014
Q2 | $54K | Hold |
670
| – | – | ﹤0.01% | 234 |
|
|
2014
Q1 | $51K | Buy |
+670
| New | +$48.8K | ﹤0.01% | 223 |
|
Other funds holding NVS
Barrett Asset Management's NVS Position: Q1 2022 in Review
Barrett Asset Management sold out of Novartis (NVS) in Q1 2022, closing a stake of 1,050 shares — an estimated $92K sold.
Barrett Asset Management first reported a position in NVS in Q1 2014 and held it in 32 quarters. The position peaked at $193K in Q3 2017. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.
- Barrett Asset Management reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
- Barrett Asset Management sold 1,050 Novartis shares in Q1 2022, an estimated $92K.
- Barrett Asset Management first reported a position in Novartis in Q1 2014 and held it in 32 quarters.
- Barrett Asset Management's Novartis position peaked at $193K in Q3 2017.
- 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.
Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.